Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 22,727 shares at $17.74 ($405K) on 2018-06-01, disclosed to the SEC on 2018-06-05.
Scheduled sale ($405k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.74 | 18,253 | $324K | 79.9% |
| 2 | $18.24 | 4,474 | $82K | 20.1% |
| Total | $17.84 avg | 22,727 | $405K | 100% |
| Filing → |
| ATHA | SELL | 2025-07-02 | $7K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $14K | — | Filing → |
| ATHA | SELL | 2024-09-05 | $3K | — | Filing → |